Working under daylight intensity lamp: An occupational risk for developing circadian rhythm sleep disorder?

Chronobiology International

Volumn 22, Issue 3, 2005, Pages 597-605

  Doljansky, J T ^a   Kannety, H ^b   Dagan, Y ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b Haim Sheba Health Center   (Israel)

Author keywords

Bright Light; Circadian Rhythm; Circadian Rhythm Sleep Disorder; Melatonin; Sleep Wake Rhythm

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CIRCADIAN RHYTHM; FLUORESCENT LIGHTING; HUMAN; LIGHT EXPOSURE; MALE; OCCUPATIONAL DISEASE; RISK ASSESSMENT; RISK FACTOR; SLEEP DISORDER; WORK ENVIRONMENT;

BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; HUMANS; LIGHT; LIGHTING; MALE; MELATONIN; MIDDLE AGED; PHOTOTHERAPY; RISK FACTORS; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 23744499226     PISSN: 07420528     EISSN: None     Source Type: Journal    
DOI: 10.1081/CBI-200062422     Document Type: Article

References (14)

1. Arendt, J. (1995). Melatonin and the Mammalian Pineal Gland. 1st ed. London: Chapman & Hall, xvi, p. 331.
2. Cajochen, C., Krauchi, K., Wirz-Justice, A. (2003). Role of melatonin in the regulation of human circadian rhythms and sleep. J. Neuroendocrinol. 15(4):432-437.
3. Dori, D., Casale, G., Solerte, S.B., Fioravanti, M., Migliorat, G., Cuzzoni, G., Ferrari, E. (1994). Chrono-neuroendocrinological aspects of physiological aging and senile dementia. Chronobiologia 21(1-2):121-126.
4. Jan, J.E., Espezel, H., Appleton, R.E. (1994). The treatment of sleep disorders with melatonin. Dev. Med. Child Neuro. 36(2):97-107.
5. Kamei, Y., Hayakawa, T., Urata, J., Uchiyama, M., Shibui, K., Kim, K., Kudo, Y., Okawa, M. (2000). Melatonin treatment for circadian rhythm sleep disorders. Psychiatry Clin. Neurosci. 54(3): 381-382.
6. Lewy, A.J., Wehr, T.A., Goodwin, F.K., Newsome, D.A., Markey, S.P. (1980). Light suppresses melatonin secretion in humans. Science 210(4475): 1267-1269.
7. Liu, R.Y., Zhou, J.N., van Heerikhuize, J., Hofman, M.A., Swaab, D.F. (1999). Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J. Clin. Endocrinol. Metab. 84(1):323-327.
8. Mishima, K., Tozawa, T., Satoh, K., Matsumoto, Y., Hishikawa, Y., Okawa, M. (1999). Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol. Psychiatry 45(4):417-421.
9. Nir, I. (2003). Melatonin for the treatment of disorders in circadian rhythm and sleep: could it form a basis for medication? Receptors Channels 9(6):379-385.
10. Okawa, M., Uchiyama, M., Ozaki, S., Shibui, K., Kamei, Y., Hayakawa, T., Urata, J. (1998). Melatonin treatment for circadian rhythm sleep disorders. Psychiatry Clin. Neurosci. 52(2):259-260.
11. Onen, F., Onen, S.H. (2003). Sleep rhythm disturbances in Alzheimer's disease-French. Rev. Med. Interne 24(3): 165-171.
12. Skene, D.J., Swaab, D.F. (2003). Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp. Gerontol. 38(1-2):199-206.
13. Touitou, Y., Portaluppi, F., Smolensky, M.H., Rensing, L. (2004). Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 21:161-170.
14. Wever, R.A. (1986). Characteristics of circadian rhythms in human functions./. Neural. Transm. Suppl. 21:323-373.